ArticleScience advances2026
Inverse scattering in biological samples via beam propagation.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Inverse-scattering of absorptive samples via beam propagation.bioRxiv : the preprint server for biology · 2026Article
- Axially Swept Light-Sheet Microscopy using scattering and fluorescence contrast mechanisms.Proceedings of SPIE--the International Society for Optical Engineering · 2026Article
Corrections and comments
- Update of
Authors and funding
14 authors.
Funding
Abstract
Multiple scattering limits optical imaging in thick biological samples by scrambling sample-specific information. Physics-based inverse-scattering methods aim to computationally unscramble this information often by using nonconvex optimization solvers. However, their inherent nonconvexity often leads to highly sample-dependent performance and inaccurate reconstructions, particularly in strongly scattering specimens. Here, we introduce a novel inverse-scattering framework based on multislice beam propagation (MSBP) that robustly achieves high-quality scatter correction and label-free volumetric imaging across a diverse range of scattering biological samples. We rigorously benchmarked imaging performance across multiple MSBP solver implementations using both scattering calibration phantoms and biological specimens. We found that an amplitude-only cost function in the inverse solver, combined with angular and defocus diversity in the scattering measurements, enabled volumetric, label-free imaging with high-quality and subcellular-level scatter correction. Together, these results establish a foundation for the reliable application of inverse scattering to achieve biologically interpretable three-dimensional imaging in increasingly thick, multicellular samples, thus introducing a new paradigm for deep-tissue computational imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.